−364KRW
13.91 BKRW
36.31 BKRW
87.63 M
About TELCON RF PHARMACEUTICAL. INC.
Sector
Industry
CEO
Ji-Hoon Kim
Website
Headquarters
Yongin-si
Employees (FY)
122
Founded
1999
ISIN
KR7200230001
FIGI
BBG007D1S7M7
TELCON RF PHARMACEUTICAL. Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. It operates through the Radio frequency (RF) business division and Pharmaceutical and bio-pharmaceutical business division. The RF business division provides connectors, cable assemblies and components. The Pharmaceutical and bio-pharmaceutical business division offers algicell solution, gud solution, livamax suspension and other drugs. The company was founded on January 8, 1999 and is headquartered in Yongin-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 200230 is 849 KRW — it has increased by 10.40% in the past 24 hours. Watch TELCON RF PHARMACEUTICAL. INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange TELCON RF PHARMACEUTICAL. INC. stocks are traded under the ticker 200230.
200230 stock has risen by 16.30% compared to the previous week, the month change is a 7.20% rise, over the last year TELCON RF PHARMACEUTICAL. INC. has showed a 29.25% decrease.
200230 reached its all-time high on Dec 7, 2017 with the price of 19450 KRW, and its all-time low was 625 KRW and was reached on Mar 6, 2024. View more price dynamics on 200230 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
200230 stock is 20.73% volatile and has beta coefficient of 1.11. Track TELCON RF PHARMACEUTICAL. INC. stock price on the chart and check out the list of the most volatile stocks — is TELCON RF PHARMACEUTICAL. INC. there?
Today TELCON RF PHARMACEUTICAL. INC. has the market capitalization of 89.20 B, it has decreased by 1.30% over the last week.
Yes, you can track TELCON RF PHARMACEUTICAL. INC. financials in yearly and quarterly reports right on TradingView.
200230 net income for the last quarter is −7.27 B KRW, while the quarter before that showed 4.07 B KRW of net income which accounts for −278.57% change. Track more TELCON RF PHARMACEUTICAL. INC. financial stats to get the full picture.
No, 200230 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 5, 2024, the company has 122.00 employees. See our rating of the largest employees — is TELCON RF PHARMACEUTICAL. INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TELCON RF PHARMACEUTICAL. INC. EBITDA is 5.13 B KRW, and current EBITDA margin is 14.35%. See more stats in TELCON RF PHARMACEUTICAL. INC. financial statements.
Like other stocks, 200230 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TELCON RF PHARMACEUTICAL. INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TELCON RF PHARMACEUTICAL. INC. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TELCON RF PHARMACEUTICAL. INC. stock shows the sell signal. See more of TELCON RF PHARMACEUTICAL. INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.